Mankind Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mankind Pharma Ltd (MNKI)
Mankind Pharma Ltd stock price live, this page displays BO MNKI stock exchange data. View the MNKI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Mankind Pharma Ltd real time stock price chart below.
What Is the Mankind Pharma Ltd Stock Price Today?
The Mankind Pharma Ltd stock price today is 2,568.90.
What Is the Stock Symbol for Mankind Pharma Ltd?
The stock symbol for Mankind Pharma Ltd is ""MNKI.""
What Stock Exchange Does Mankind Pharma Ltd Trade On?
Mankind Pharma Ltd is listed and trades on the BSE stock exchange.
Is Mankind Pharma Ltd a Good Stock to Buy?
Determining whether Mankind Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MNKI quote. (ISIN: INE634S01028)
What Is the Mankind Pharma Ltd Stock Price Today?
The Mankind Pharma Ltd stock price today is 2,568.90.
What Is the Stock Symbol for Mankind Pharma Ltd?
The stock symbol for Mankind Pharma Ltd is ""MNKI.""
What Stock Exchange Does Mankind Pharma Ltd Trade On?
Mankind Pharma Ltd is listed and trades on the BSE stock exchange.
Is Mankind Pharma Ltd a Good Stock to Buy?
Determining whether Mankind Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MNKI quote. (ISIN: INE634S01028)
2,568.90
+9.80(+0.38%)
Closed·
Fair Value
An estimate of a Mankind Pharma Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,563.20
2,610.10
52 wk Range
2,115.10
3,054.80
MNKI Scorecard
Full Analysis
Trading at a high earnings multiple
MNKI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Mankind Pharma Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,563.202,610.10
52 wk Range
2,115.103,054.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.04%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.04%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MNKI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Mankind Pharma Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
2,799.65
Upside
+8.98%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
- BofA cuts Mankind Pharma stock target to INR2,150
- Investing.com
- Mankind Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mankind Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mankind Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Mankind Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mankind Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mankind Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mankind Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Mankind Pharma Ltd Company Profile
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. In addition, the company engages in the trading and exporting of pharmaceutical and health care products; manufacture of packing materials, ayurvedic products, and consumer goods; real estate, leasing, and hospitality businesses; trading of agricultural products; and provision of IT services. It offers its products under the Manforce, Moxi Kind-Cv, AmLokind-At, Unwanted-Kit, Prega News, Dydroboon, Gudcef, Candi Force, Glimestar-M, Telmikind-Am, Nurokind-Gold, Telmikind-H, Nurokind-Lc, Telmikind, Vomikind, Cefakind, Nurokind Plus-Rf, Gudcef-Cv, Monticope, and Asthakind-Dx brand names. Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi, India.
Compare MNKI to Peers and Sector
Metrics to compare | MNKI | Peers Peers - average of corresponding metrics from companies closely matching MNKI: MOREPENLAB, LUPIN, JBCHEPHARM, EMCURE, ABBOTINDIA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMNKIPeersSector |
|---|---|---|---|---|
P/E Ratio | 56.0x | 30.3x | −0.6x | |
PEG Ratio | −10.98 | 0.93 | 0.00 | |
Price/Book | 7.4x | 5.3x | 2.6x | |
Price / LTM Sales | 8.2x | 4.6x | 3.3x | |
Upside (Analyst Target) | 10.0% | 13.5% | 39.4% | |
Fair Value Upside | Unlock | −1.1% | 4.9% | Unlock |
Analyst Ratings
13 Buy
2 Hold
2 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2,799.65
(+8.98% Upside)
Earnings
Latest Release
Jul 31, 2025
EPS / Forecast
10.70 / 11.02
Revenue / Forecast
35.70B / 36.05B
People Also Watch
FAQ
What Stock Exchange Does Mankind Pharma Ltd Trade On?
Mankind Pharma Ltd is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Mankind Pharma Ltd?
The stock symbol for Mankind Pharma Ltd is "MNKI."
What Is the Mankind Pharma Ltd Market Cap?
As of today, Mankind Pharma Ltd market cap is 1.06T.
What Is Mankind Pharma Ltd's Earnings Per Share (TTM)?
The Mankind Pharma Ltd EPS (TTM) is 46.51.
When Is the Next Mankind Pharma Ltd Earnings Date?
Mankind Pharma Ltd will release its next earnings report on 03 Nov 2025.
From a Technical Analysis Perspective, Is MNKI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Mankind Pharma Ltd Stock Split?
Mankind Pharma Ltd has split 0 times.
How Many Employees Does Mankind Pharma Ltd Have?
Mankind Pharma Ltd has 26978 employees.
What is the current trading status of Mankind Pharma Ltd (MNKI)?
As of 04 Sept 2025, Mankind Pharma Ltd (MNKI) is trading at a price of 2,568.90, with a previous close of 2,559.10. The stock has fluctuated within a day range of 2,563.20 to 2,610.10, while its 52-week range spans from 2,115.10 to 3,054.80.
What Is Mankind Pharma Ltd (MNKI) Price Target According to Analysts?
The average 12-month price target for Mankind Pharma Ltd is INR2799.64706, with a high estimate of INR3300 and a low estimate of INR2150. 13 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +8.98% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.